(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione

C50H59F2N11O5 — CID 176725115

IUPAC(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione
SMILESCOC[C@H]1CN(c2ccc3nc4n(c3c2)C[C@@H]2CC[C@H](COc3c(cnn3C)-c3cc(cc(C)n3)C(=O)N4)C2)CCN1C1CN(C2CCN(c3cc(F)c([C@H]4CCC(=O)NC4=O)c(F)c3)CC2)C1
InChIInChI=1S/C50H59F2N11O5/c1-29-16-32-18-43(54-29)39-22-53-58(2)49(39)68-27-31-5-4-30(17-31)23-63-44-21-34(6-8-42(44)55-50(63)57-47(32)65)60-14-15-62(37(26-60)28-67-3)36-24-61(25-36)33-10-12-59(13-11-33)35-19-40(51)46(41(52)20-35)38-7-9-45(64)56-48(38)66/h6,8,16,18-22,30-31,33,36-38H,4-5,7,9-15,17,23-28H2,1-3H3,(H,55,57,65)(H,56,64,66)/t30-,31+,37-,38-/m1/s1
InChIKeyCDWLAILVWZVYFH-XTYWNXKGSA-N
MW932.09 g/mol
LogP5.49
Rot. Bonds7

About (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione

(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione (PubChem CID 176725115) has the molecular formula C50H59F2N11O5 and a molecular weight of 932.09 g/mol. Its IUPAC name is (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione.

Molecular Properties

Compound Name(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione
PubChem CID176725115
Molecular FormulaC50H59F2N11O5
Molecular Weight932.09 g/mol
Exact Mass931.47
IUPAC Name(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione
SMILESCOC[C@H]1CN(c2ccc3nc4n(c3c2)C[C@@H]2CC[C@H](COc3c(cnn3C)-c3cc(cc(C)n3)C(=O)N4)C2)CCN1C1CN(C2CCN(c3cc(F)c([C@H]4CCC(=O)NC4=O)c(F)c3)CC2)C1
InChIInChI=1S/C50H59F2N11O5/c1-29-16-32-18-43(54-29)39-22-53-58(2)49(39)68-27-31-5-4-30(17-31)23-63-44-21-34(6-8-42(44)55-50(63)57-47(32)65)60-14-15-62(37(26-60)28-67-3)36-24-61(25-36)33-10-12-59(13-11-33)35-19-40(51)46(41(52)20-35)38-7-9-45(64)56-48(38)66/h6,8,16,18-22,30-31,33,36-38H,4-5,7,9-15,17,23-28H2,1-3H3,(H,55,57,65)(H,56,64,66)/t30-,31+,37-,38-/m1/s1
InChIKeyCDWLAILVWZVYFH-XTYWNXKGSA-N
XLogP5.49
TPSA155.22 Ų
H-Bond Donors2
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms68
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500932.09
LogP ≤ 55.49
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione?
The IUPAC name of (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione (CID 176725115) is (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione.
What is the SMILES notation for (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione?
The canonical SMILES for (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione is COC[C@H]1CN(c2ccc3nc4n(c3c2)C[C@@H]2CC[C@H](COc3c(cnn3C)-c3cc(cc(C)n3)C(=O)N4)C2)CCN1C1CN(C2CCN(c3cc(F)c([C@H]4CCC(=O)NC4=O)c(F)c3)CC2)C1.
What is the InChIKey of (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione?
The InChIKey is CDWLAILVWZVYFH-XTYWNXKGSA-N. The full InChI is InChI=1S/C50H59F2N11O5/c1-29-16-32-18-43(54-29)39-22-53-58(2)49(39)68-27-31-5-4-30(17-31)23-63-44-21-34(6-8-42(44)55-50(63)57-47(32)65)60-14-15-62(37(26-60)28-67-3)36-24-61(25-36)33-10-12-59(13-11-33)35-19-40(51)46(41(52)20-35)38-7-9-45(64)56-48(38)66/h6,8,16,18-22,30-31,33,36-38H,4-5,7,9-15,17,23-28H2,1-3H3,(H,55,57,65)(H,56,64,66)/t30-,31+,37-,38-/m1/s1.
What are the key properties of (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione?
(3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione has a molecular weight of 932.09 g/mol, XLogP of 5.49, 7 rotatable bonds, 2 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-3-[4-[4-[3-[(2R)-4-[(9S,12R)-5,27-dimethyl-24-oxo-7-oxa-4,5,14,21,23,28-hexazahexacyclo[23.3.1.19,12.02,6.014,22.015,20]triaconta-1(28),2(6),3,15(20),16,18,21,25(29),26-nonaen-17-yl]-2-(methoxymethyl)piperazin-1-yl]azetidin-1-yl]piperidin-1-yl]-2,6-difluorophenyl]piperidine-2,6-dione is sourced from PubChem (CID 176725115), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).